Valuation: Camurus AB

Market Cap 3.96TCr 399.23Cr 356.52Cr 329.35Cr 298.47Cr 558.39Cr 38TCr 567.63Cr 1.57TCr 20TCr 1.5TCr 1.47TCr 63TCr P/E 2026 *
42x
P/E 2027 * 28.1x
Enterprise Value 3.51TCr 354.05Cr 316.17Cr 292.08Cr 264.69Cr 495.2Cr 34TCr 503.39Cr 1.39TCr 18TCr 1.33TCr 1.3TCr 56TCr EV / Sales 2026 *
12.3x
EV / Sales 2027 * 9.11x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day-0.52%
1 week+3.02%
Current month+6.65%
1 month+8.12%
3 months+8.12%
6 months+24.02%
Current year+8.12%
1 week 640
Extreme 640
674.5
1 month 608
Extreme 608
674.5
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
710
3 years 320.8
Extreme 320.8
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
07/08/26 Sell

Executive/Senior Manager

-5,800 0.0096%
27/02/26 Sell

Chief Executive Officer

55,550 0.0928%
27/02/26 Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
-0.52%+3.02%+6.73%+96.69% 399.23Cr
-2.54%+1.31%+54.27%+114.96% 1,13500Cr
-1.42%+3.23%+38.56%+74.44% 64TCr
+0.16%+0.08%+25.29%+95.23% 50TCr
-0.31%+3.09%+44.14%+64.80% 38TCr
-1.34%-0.47%+66.04%+41.00% 36TCr
-0.68%+2.65%+22.98%+50.39% 29TCr
-1.20%+3.04%+2.33%+22.86% 27TCr
-1.79%+1.57%+50.56%+59.08% 24TCr
-0.73%-0.10%+29.02%+99.67% 19TCr
Average -1.04%+2.25%+33.99%+71.91% 40.08TCr
Weighted average by Cap. -1.34%+2.66%+40.99%+79.77%

Financials

2026 *2027 *
Net sales 285.39Cr 29Cr 26Cr 24Cr 21Cr 40Cr 2.73TCr 41Cr 112.99Cr 1.43TCr 107.89Cr 105.59Cr 4.51TCr 372.58Cr 38Cr 34Cr 31Cr 28Cr 52Cr 3.56TCr 53Cr 147.51Cr 1.87TCr 140.85Cr 137.85Cr 5.89TCr
Net income 95Cr 9.55Cr 8.53Cr 7.88Cr 7.14Cr 13Cr 906.62Cr 14Cr 38Cr 475.01Cr 36Cr 35Cr 1.5TCr 141.59Cr 14Cr 13Cr 12Cr 11Cr 20Cr 1.35TCr 20Cr 56Cr 709.4Cr 54Cr 52Cr 2.24TCr
Net Debt -448.52Cr -45Cr -40Cr -37Cr -34Cr -63Cr -4.29TCr -64Cr -177.57Cr -2.25TCr -169.56Cr -165.95Cr -7.08TCr -570.49Cr -57Cr -51Cr -47Cr -43Cr -80Cr -5.46TCr -82Cr -225.86Cr -2.86TCr -215.67Cr -211.08Cr -9.01TCr
Projected Income Statement - Annual - Camurus AB
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
23/26/23 SEK 666.00 -0.52% 49,592
22/26/22 SEK 669.50 -0.07% 78,976
21/26/21 SEK 670.00 +0.90% 74,248
20/26/20 SEK 664.00 +2.47% 91,786
19/26/19 SEK 648.00 +0.23% 61,772
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Camurus AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
666.00SEK
Average target price
807.25SEK
Spread / Average Target
+21.21%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Camurus AB
  1. Stock Market
  2. Stocks
  3. CAMX Stock